F2RL1 and neoplasm: Based on the results in vivo demonstrating that PAR2 knockdown in LX-2 cells resulted in remarkably reduced tumour growth in a xenograft SCID mouse model, we set out to analyse in more detail how PAR2 impacts on LX-2 cells.